Literature DB >> 10198986

[Age at disease onset and delayed diagnosis of spondyloarthropathies].

E Feldtkeller.   

Abstract

A questionnaire with 78 questions concerning the situation of ankylosing spondylitis (AS) sufferers in Germany was distributed to a representative 3000 out of the more than 14,000 patient members of the German AS society; 1614 patients (54%) responded. The age distribution of these patients roughly agrees with that expected due to the distribution of the age at diagnosis and the age distribution of the German population. The group of patients more than 65 years old is, however, under-represented. It turned out that at least 28% of the patients responding do not suffer from idiopathic AS but from other spondyloarthritides (spondylitic psoriasis, spondyloarthritis combined with Crohn's disease or ulcerative colitis). The distribution of the age at disease onset agrees well with that published in 1984 by van der Linden et al.: For 4% of the patients, the age at appearance of the first spondylitic symptoms was less than 15 years, for 90% it was 15-40 years and for the remaining 6% more than 40 years. The average age at disease onset was 25.6 years. The spondyloarthritides do not differ significantly in the distribution of the age at the first spondylitic symptoms. The distribution of the age at diagnosis did not differ significantly between male and female patients, in contrast to the findings by van der Linden et al. in 1984. The average age at diagnosis was 34.3 and 35.3 years for male and female patients, respectively. The resulting mean diagnosis delay for male and female patients was 8.4 and 9.8 years, respectively. Whereas the average diagnosis delay was still 15 years for patients with disease onset in the 1950s, it was only 71/2 years for patients with disease onset in 1975-79. It is not yet possible to predict if an average diagnosis delay less than 71/2 years results for patients with a disease onset later than 1980, because the number of further diagnoses to be expected for patients with disease onset in these years is not negligible. Twenty-six percent of the patients (22% of the males, 34% of the females) have relatives, likewise, suffering from AS. Whereas patients with familiar AS experience their first spondylitic symptoms, in the average, 11/2 years earlier than patients without relatives suffering from AS, the difference is 5 years for patients suffering from spondyloarthritis combined with ulcerative colitis. Reports written for patients on other results of the survey can be found in the newsletter "Bechterew-Brief" of the Deutsche Vereinigung Morbus Bechterew.

Entities:  

Mesh:

Year:  1999        PMID: 10198986     DOI: 10.1007/s003930050149

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  17 in total

1.  Infection and work stress are potential triggers of ankylosing spondylitis.

Authors:  Jane Zochling; Martin H J Bohl-Bühler; Xenofon Baraliakos; Ernst Feldtkeller; Jürgen Braun
Journal:  Clin Rheumatol       Date:  2006-04-22       Impact factor: 2.980

Review 2.  [Ankylosing spondylitis--current state of imaging including scoring methods].

Authors:  C E Althoff; K G Hermann; J Braun; J Sieper
Journal:  Z Rheumatol       Date:  2006-12       Impact factor: 1.372

3.  The high prevalence of infections and allergic symptoms in patients with ankylosing spondylitis is associated with clinical symptoms.

Authors:  Jane Zochling; Martin H J Bohl-Bühler; Xenofon Baraliakos; Ernst Feldtkeller; Jürgen Braun
Journal:  Clin Rheumatol       Date:  2005-12-23       Impact factor: 2.980

4.  Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis--a population-based survey.

Authors:  Jane Zochling; Martin H J Bohl-Bühler; Xenofon Baraliakos; Ernst Feldtkeller; Jürgen Braun
Journal:  Clin Rheumatol       Date:  2006-03-10       Impact factor: 2.980

5.  Definition of disease duration in ankylosing spondylitis.

Authors:  Ernst Feldtkeller; Jon Erlendsson
Journal:  Rheumatol Int       Date:  2007-12-12       Impact factor: 2.631

6.  [Health care and disease burden in persons with axial spondyloarthritis in Germany].

Authors:  H Haibel; I Redeker; A Zink; J Callhoff; U Marschall; F Hoffmann; J Sieper; D Poddubnyy
Journal:  Z Rheumatol       Date:  2019-11       Impact factor: 1.372

7.  Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis.

Authors:  Klaus Krüger; Ulrich von Hinüber; Florian Meier; Haijun Tian; Katharina Böhm; Steffen M Jugl; Kathrin Borchert; Dominic Meise; Christine König; Sebastian Braun
Journal:  Rheumatol Int       Date:  2018-08-09       Impact factor: 2.631

8.  Prevalence and annual incidence of vertebral fractures in patients with ankylosing spondylitis.

Authors:  Ernst Feldtkeller; Debby Vosse; Piet Geusens; Sjef van der Linden
Journal:  Rheumatol Int       Date:  2005-03-11       Impact factor: 2.631

9.  [Advice for patients diagnosed with ankylosing spondylitis: results of a representative patient survey in Germany].

Authors:  E Feldtkeller; L Hammel; C Brenneis; I-H Song; M Rudwaleit
Journal:  Z Rheumatol       Date:  2011-07       Impact factor: 1.372

10.  Clinical characteristics of patients with ankylosing spondylitis in India.

Authors:  Rohit Aggarwal; Anand N Malaviya
Journal:  Clin Rheumatol       Date:  2009-07-18       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.